ID93/GLA-SE boosts the immune reaction induced by BCG. Only three injections of ID93/GLA-SE exhibits prevention to
TB infection. Completed Phase I studies in the USA; Phase I completed, and Phase II initiated in South Africa.
It doesn’t interfere with current diagnostics, such as TST (Tuberculin Skin Test) or IGRA (Interferon-gamma Releasing Assay) test.